Following promising clinical results, retatrutide, a new peptide therapy for managing adult-onset metabolic disorder, has obtained regulatory approval from Great Britain's Drug and Regulatory Agency ( https://rishioxvy511738.thezenweb.com/retatrutide-compound-peptide-united-kingdom-authorization-and-launch-79724468